William J. Blot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
William J. Blot has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Joseph F. Fraumeni
4 shared publicationsMichel A. Ibrahim
2 shared publications- Ann W. Hsing
Stanford Cancer Center, Stanford University, Palo Alto, CA, US
1 shared publication Arthur Weyman
From the International Epidemiology Institute (W.J.B.), Rockville, Md; Johns Hopkins University (M.A.I., R.B.), Baltimore, Md; the Cardiac Surgery Institute (T.D.I.), Cincinnati, Ohio; London, England (D.E.A.); Massachusetts General Hospital (A.W.), Boston, Mass; Saint Antonius Hospital (J.D.), Nieuwegein, the Netherlands; Trustees Bowling-Pfizer Settlement Funds (J.K.S.), Cincinnati, Ohio; and the University of Cincinnati (D.H.), Cincinnati, Ohio
1 shared publicationB. J. Stone
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
1 shared publicationDeborah M. Winn
1 shared publication
Latest Publications
- 1 November 2007
- Vol. 16 (6) , 657-661
Single leg separation prevalence among explanted Bjork-Shiley prosthetic heart valves
Background and aim of the study: Bjork-Shiley convexo-concave (BSCC) prosthetic heart valves are believed to have been implanted in over 86,000 patients worldwide. Limited data are available on the prevalence of single leg separations (SLS) of the valves' outlet struts, a potential precursor to complete valve fracture. Methods: Data maintained by the manufacturer, including results of examinations for SLS in explanted valves, were merged with available information on the characteristics of the valve. The prevalence of SLS in the examined valves was calculated according to valve angle, size, position, and study. Results: Among 343 examined valves, the overall prevalence of SLS was 8.2%, but this varied significantly by valve size, being three-fold higher among 29+ mm valves than among smaller valves, with statistically non-significantly higher prevalences among mitral than aortic, and among 70 degrees than 60 degrees valves. By applying the size, position and angle-specific SLS prevalences to the worldwide valve distribution, it is estimated that SLS may be present in 6.8% (95% confidence limits 4.1-9.4%) of all BSCC valves. Conclusion: These findings suggest that SLS may affect between 820 and 1,880 of the almost 20,000 BSCC valves among surviving patients worldwide. Such estimates help frame the context for potential patient screenings, should imaging and acoustic techniques to detect SLS become available.
- 1 November 2007
- Vol. 16 (6) , 657-661
Single leg separation prevalence among explanted Bjork-Shiley prosthetic heart valves
Background and aim of the study: Bjork-Shiley convexo-concave (BSCC) prosthetic heart valves are believed to have been implanted in over 86,000 patients worldwide. Limited data are available on the prevalence of single leg separations (SLS) of the valves' outlet struts, a potential precursor to complete valve fracture. Methods: Data maintained by the manufacturer, including results of examinations for SLS in explanted valves, were merged with available information on the characteristics of the valve. The prevalence of SLS in the examined valves was calculated according to valve angle, size, position, and study. Results: Among 343 examined valves, the overall prevalence of SLS was 8.2%, but this varied significantly by valve size, being three-fold higher among 29+ mm valves than among smaller valves, with statistically non-significantly higher prevalences among mitral than aortic, and among 70 degrees than 60 degrees valves. By applying the size, position and angle-specific SLS prevalences to the worldwide valve distribution, it is estimated that SLS may be present in 6.8% (95% confidence limits 4.1-9.4%) of all BSCC valves. Conclusion: These findings suggest that SLS may affect between 820 and 1,880 of the almost 20,000 BSCC valves among surviving patients worldwide. Such estimates help frame the context for potential patient screenings, should imaging and acoustic techniques to detect SLS become available.
- 31 May 2005
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (21) , 2850-2857
Twenty-Five–Year Experience With the Björk-Shiley Convexoconcave Heart Valve
Background— The first Björk-Shiley convexoconcave (BSCC) prosthetic heart valves were implanted in 1978. The 25th anniversary provided a stimulus to summarize the research data relevant to BSCC valve fracture, patient management, and current clinical options. Methods and Results— Published and unpublished data on the risks of BSCC valve fracture and replacement were compiled, and strategies for identifying candidates for prophylactic valve reoperation were summarized. By December 2003, outlet strut fractures (OSFs), often with fatal outcomes, had been reported in 633 BSCC valves (0.7% of 86 000 valves implanted). Fractures still continue to occur, but average rates of OSFs in 60° valves are now Conclusions— Twenty-five years after the initial BSCC valve implants, fractures continue to occur. Continued monitoring of BSCC patients is needed to track and quantify risks and enable periodic updating of guidelines for patients and their physicians.
- 31 May 2005
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (21) , 2850-2857
Twenty-Five–Year Experience With the Björk-Shiley Convexoconcave Heart Valve
Background— The first Björk-Shiley convexoconcave (BSCC) prosthetic heart valves were implanted in 1978. The 25th anniversary provided a stimulus to summarize the research data relevant to BSCC valve fracture, patient management, and current clinical options. Methods and Results— Published and unpublished data on the risks of BSCC valve fracture and replacement were compiled, and strategies for identifying candidates for prophylactic valve reoperation were summarized. By December 2003, outlet strut fractures (OSFs), often with fatal outcomes, had been reported in 633 BSCC valves (0.7% of 86 000 valves implanted). Fractures still continue to occur, but average rates of OSFs in 60° valves are now Conclusions— Twenty-five years after the initial BSCC valve implants, fractures continue to occur. Continued monitoring of BSCC patients is needed to track and quantify risks and enable periodic updating of guidelines for patients and their physicians.
- 1 January 2004
- Published by Begell House Inc. Publishers in Journal of Long-Term Effects of Medical Implants
- Vol. 14 (5) , 6
Outstanding Scientist of 2004Joseph K. McLaughlin, PhDA World Leader in Implant Research
Objective. To describe the key contributions of Dr. Joseph K. McLaughlin, Outstanding Scientist of 2004. Methods. We review the scientific literature and indicate how epidemiologic research conducted by Dr. McLaughlin has clarified long-term health effects among persons with breast and other medical implants. Results. Dr. Joseph K. McLaughlin has conducted and directed more research into the long-term effects of human implants than any other scientist worldwide. His insights greatly elucidated the long-term health consequences associated with a variety of implanted devices, including silicone and saline breast implants, hip and knee replacements, temporomandibular and finger joint devices, and pacemakers. By initiating and bringing to fruition a series of innovative epidemiologic investigations, Dr. McLaughlin and his colleagues have provided the scientific basis for making judgments about alleged adverse health effects following cosmetic, reconstructive, and reparative implant surgery. Conclusions. Dr. McLaughlin's seminal investigations have provided reassurance that breast and other implants have not demonstrably increased the risk of cancer or other systemic diseases. The comprehensive and rigorous nature of this research merits his selection as Outstanding Scientist of 2004.
- 1 January 2004
- Published by Begell House Inc. Publishers in Journal of Long-Term Effects of Medical Implants
- Vol. 14 (5) , 6
Outstanding Scientist of 2004Joseph K. McLaughlin, PhDA World Leader in Implant Research
Objective. To describe the key contributions of Dr. Joseph K. McLaughlin, Outstanding Scientist of 2004. Methods. We review the scientific literature and indicate how epidemiologic research conducted by Dr. McLaughlin has clarified long-term health effects among persons with breast and other medical implants. Results. Dr. Joseph K. McLaughlin has conducted and directed more research into the long-term effects of human implants than any other scientist worldwide. His insights greatly elucidated the long-term health consequences associated with a variety of implanted devices, including silicone and saline breast implants, hip and knee replacements, temporomandibular and finger joint devices, and pacemakers. By initiating and bringing to fruition a series of innovative epidemiologic investigations, Dr. McLaughlin and his colleagues have provided the scientific basis for making judgments about alleged adverse health effects following cosmetic, reconstructive, and reparative implant surgery. Conclusions. Dr. McLaughlin's seminal investigations have provided reassurance that breast and other implants have not demonstrably increased the risk of cancer or other systemic diseases. The comprehensive and rigorous nature of this research merits his selection as Outstanding Scientist of 2004.
- Open Access
- 10 November 1999
- Published by Wiley in International Journal of Cancer
- Vol. 83 (5) , 615-619
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer
- 10 November 1999
- Published by Wiley in International Journal of Cancer
- Vol. 83 (5) , 615-619
Open AccessEvolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer
- 1 July 1996
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 30 (1) , 7-15
Cancer risks among iron and steel workers in Anshan, China, part II: Case‐control studies of lung and stomach cancer
- 1 July 1996
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 30 (1) , 7-15
Cancer risks among iron and steel workers in Anshan, China, part II: Case‐control studies of lung and stomach cancer
- 1 January 1990
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 13 (3) , 121-127
Correlations of dietary intake and blood nutrient levels with esophageal cancer mortality in China
Using dietary, blood nutrient, and esophageal cancer mortality data from 65 Chinese counties, we examined several correlations to help provide clues to the influence of diet and nutrition on the geographic variation of esophageal cancer in China. Esophageal cancer mortality was significantly inversely related to reported fruit consumption and to plasma ascorbic acid concentration. The age‐adjusted mortality rates were more than three times higher for counties in the lowest compared with the highest quartile of fruit intake or plasma vitamin C. Positive correlations with intake of moldy vegetables were observed but not with tobacco and alcohol consumption. There were suggestive inverse associations with blood selenium and riboflavin but little effect of fat‐soluble vitamins. Limitations of ecological data preclude causal inferences, but the relationships provide leads to dietary factors that may contribute to the exceptionally high rates of esophageal cancer in several areas of China.
- 1 January 1990
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 13 (3) , 121-127
Correlations of dietary intake and blood nutrient levels with esophageal cancer mortality in China
Using dietary, blood nutrient, and esophageal cancer mortality data from 65 Chinese counties, we examined several correlations to help provide clues to the influence of diet and nutrition on the geographic variation of esophageal cancer in China. Esophageal cancer mortality was significantly inversely related to reported fruit consumption and to plasma ascorbic acid concentration. The age‐adjusted mortality rates were more than three times higher for counties in the lowest compared with the highest quartile of fruit intake or plasma vitamin C. Positive correlations with intake of moldy vegetables were observed but not with tobacco and alcohol consumption. There were suggestive inverse associations with blood selenium and riboflavin but little effect of fat‐soluble vitamins. Limitations of ecological data preclude causal inferences, but the relationships provide leads to dietary factors that may contribute to the exceptionally high rates of esophageal cancer in several areas of China.
- 1 February 1983
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 70 (2) , 251-253
Oral Cancer and Mouthwash
As part of a case-control study in North Carolina involving 206 women with oral and pharyngeal cancers and 352 controls, questions were asked concerning the patterns of mouthwash use. No significant overall increase in risk was found among users; the relative risk, adjusted for snuff dipping and smoking habits, was 1.15 [lower, upper limits of the 95% confidence interval (95% CI) = 0.8, 1.7]. The relative risk associated with mouthwash use was increased to 1.94 (95% CI = 0.8, 4.7), however, among women abstaining from tobacco. Although consistent dose-response relationships were not observed for this subgroup, these findings and other reports of an increased risk among persons ordinarily at low risk of this disease raise the possibility that mouthwash may contribute to oral and pharyngeal cancers.
- 1 February 1983
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 70 (2) , 251-253
Oral Cancer and Mouthwash
As part of a case-control study in North Carolina involving 206 women with oral and pharyngeal cancers and 352 controls, questions were asked concerning the patterns of mouthwash use. No significant overall increase in risk was found among users; the relative risk, adjusted for snuff dipping and smoking habits, was 1.15 [lower, upper limits of the 95% confidence interval (95% CI) = 0.8, 1.7]. The relative risk associated with mouthwash use was increased to 1.94 (95% CI = 0.8, 4.7), however, among women abstaining from tobacco. Although consistent dose-response relationships were not observed for this subgroup, these findings and other reports of an increased risk among persons ordinarily at low risk of this disease raise the possibility that mouthwash may contribute to oral and pharyngeal cancers.